References
- CSSE. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University 2020. Available from: https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6.
- Moreno P, Moratorio GA, Iraola G, et al. An effective COVID-19 response in South America: the Uruguayan Conundrum. medRxiv. 2020:2020.07.24.20161802.
- INE. Global Health Data Exchange Washington2020 [cited 2020 September 8]. Available from: http://ghdx.healthdata.org/organizations/national-institute-statistics-uruguay.
- IMPO. Decreto No. 93/020: Declaracion de Estado de Emergencia Nacional Sanitaria como Consecuencia de la Pandemia Originada por el Virus COVID-19 (Coronavirus) Uruguay: Registro Nacional de Leyes y Decretos [Decree No. 93/020: Declaration of a state of national health emergency as a consequence of the pandemic originated by the COVID-19 virus (Coronavirus) Uruguay: National Registry of Laws and Decrees]; 2020 [cited 2020 September 4]. Available from: https://www.impo.com.uy/bases/decretos/93-2020. Spanish.
- IMPO. Decreto No. 104/020: Autorizacion del Ingreso al Pais Unicamente de Ciudadanos Uruguayos y Extranjeros Residentes Provenientes del Exterior Uruguay: Registro Nacional de Leyes y Decretos [Decree No. 104/020: Entry authorization to the country only for Uruguayan citizens and resident foreigners from abroad Uruguay: National Registry of Laws and Decrees]; 2020 [cited 2020 September 4]. Available from: http://www.impo.com.uy/bases/decretos/104-2020. Spanish.
- SNE. Visualizador de casos coronavirus COVID-19 en Uruguay [Viewer of coronavirus COVID-19 cases in Uruguay 2020]; 2020 [cited 2020 September 15]. Available from: https://www.gub.uy/sistema-nacional-emergencias/pagina-embebida/visualizador-casos-coronavirus-covid-19-uruguay. Spanish.
- Salazar C, Díaz-Viraqué F, Pereira-Gómez M, et al. Multiple introductions, regional spread and local differentiation during the first week of COVID-19 epidemic in Montevideo, Uruguay. bioRxiv. 2020:2020.05.09.086223.
- Candido DS, Claro IM, de Jesus JG, et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020 Sep 4; 369(6508):1255–1260.
- Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, et al. Introductions and early spread of SARS-CoV-2 in the New York city area. Science. 2020 Jul 17;369(6501):297–301.
- Dellicour S, Durkin K, Hong SL, et al. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages. Mol Biol Evol. 2020 Nov 3; msaa284.
- Maurano MT, Ramaswami S, Zappile P, et al. Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York city region. Genome Res. 2020 Oct 22;30(12):1781–1788.
- Uruguay Presidencia. COVID-19: Hay 129 casos activos en seis departamentos [COVID-19: there are 129 active cases in six departments]; 2020. Available from: https://www.presidencia.gub.uy/comunicacion/comunicacionnoticias/informe-sinae-martes-26. Spanish.
- Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018 Dec 1;34(23):4121–4123.
- MINISTERIO DE SALUD PÚBLICA. COVID-19 Vigilancia y diagnóstico laboratorial [COVID-19 surveillance and laboratory diagnosis]; 2020. Available from: https://www.gub.uy/ministerio-salud-publica/sites/ministerio-salud-publica/files/documentos/noticias/03_MSP_COVID_19_VIGILANCIA_DIAGNOSTICO_FINAL.pdf. Spanish.
- MINISTERIO DE SALUD PÚBLICA. Plan Nacional de Contingencia para la Infección (COVID-19) por el nuevo Coronavirus (SARS CoV2) [National contingency plan for infection (COVID-19) by the new coronavirus (SARS CoV2)]; 2020. Available from: https://www.gub.uy/ministerio-salud-publica/sites/ministerio-salud-publica/files/documentos/noticias/01_MSP_COVID_19_PLAN_NACIONAL_CONTINGENCIA_GESTION_RESPUESTA.pdf. Spanish.
- Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011 Oct;28(10):2731–2739.
- Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Brief Bioinform. 2019 Jul 19;20(4):1160–1166.
- Los Alamos National Laboratory tools. Highlighter tool 2020. Available from: http://www.hiv.lanl.gov/.
- Nguyen LT, Schmidt HA, von Haeseler A, et al. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015 Jan;32(1):268–274.
- Rambaut A, Lam TT, Max Carvalho L, et al. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016 Jan;2(1):vew007.
- Sagulenko P, Puller V, Neher RA. Treetime: maximum-likelihood phylodynamic analysis. Virus Evol. 2018 Jan;4(1):vex042.
- Suchard MA, Lemey P, Baele G, et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018 Jan;4(1):vey016.
- Rambaut A, Drummond AJ. Tracer v1.5. 2009.
- Rambaut A, Drummond AJ, Xie D, et al. Posterior Summarization in Bayesian phylogenetics using Tracer 1.7. Syst Biol. 2018 Sep 1;67(5):901–904.
- Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265–269.
- Mercatelli D, Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol. 2020;11:1800.
- Bryner J. 1st known case of coronavirus traced back to November in China 2020. Available from: https://www.livescience.com/first-case-coronavirus-found.html.
- Nie Q, Li X, Chen W, et al. Phylogenetic and phylodynamic analyses of SARS-CoV-2. Virus Res. 2020 Oct 2;287:198098.
- van Dorp L, Acman M, Richard D, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020 Sep;83:104351.
- Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020 Apr;26(4):450–452.
- Castillo AE, Parra B, Tapia P, et al. Geographical distribution of genetic variants and Lineages of SARS-CoV-2 in Chile. Front Public Health. 2020;8:562615.
- Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020 Aug 20;182(4):812–827.e19.
- Ilmjärv S, Abdul F, Acosta-Gutiérrez S, et al. Epidemiologically most successful SARS-CoV-2 variant: concurrent mutations in RNA-dependent RNA polymerase and spike protein. medRxiv. 2020:2020.08.23.20180281.
- CoV-GLUE. CoV-GLUE - Amino acid replacements 2020. Available from: http://cov-glue.cvr.gla.ac.uk/#/replacement.
- Wang R, Chen J, Gao K, et al. Characterizing SARS-CoV-2 mutations in the United States. Res Sq. 2020 Aug 11.
- Liu Q, Zhao S, Hou Y, et al. Ongoing natural selection drives the evolution of SARS-CoV-2 genomes. medRxiv. 2020:2020.09.07.20189860.
- Chaw SM, Tai JH, Chen SL, et al. The origin and underlying driving forces of the SARS-CoV-2 outbreak. J Biomed Sci. 2020 Jun 7;27(1):73.
- Portelli S, Olshansky M, Rodrigues CHM, et al. COVID-3D: an online resource to explore the structural distribution of genetic variation in SARS-CoV-2 and its implication on therapeutic development. bioRxiv. 2020:2020.05.29.124610.
- Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv. 2020:2020.06.12.148726.
- Li Q, Wu J, Nie J, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020 Sep 3;182(5):1284–1294.e9.
- Yurkovetskiy L, Wang X, Pascal KE, et al. Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell. 2020 Oct 29;183(3):739–751 e8.
- Mansbach RA, Chakraborty S, Nguyen K, et al. The SARS-CoV-2 spike variant D614G favors an open conformational state. bioRxiv. 2020:2020.07.26.219741.
- Baum A, Fulton BO, Wloga E, et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020 Aug 21;369(6506):1014–1018.
- Weissman D, Alameh M-G, de Silva T, et al. D614G spike mutation increases SARS CoV-2 susceptibility to neutralization. Cell Host Microbe. 2020 Dec 1:S1931-3128(20)30634-X
- Sahin U, Muik A, Derhovanessian E, et al. Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine. medRxiv. 2020:2020.07.17.20140533.
- Pachetti M, Marini B, Benedetti F, et al. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Transl Med. 2020 Apr 22;18(1):179.
- Castillo AE, Parra B, Tapia P, et al. Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile. J Med Virol. 2020 Mar 29;92(9):1562–1566.
- Padilla-Rojas C, Lope-Pari P, Vega-Chozo K, et al. Near-complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2) strain causing a COVID-19 case in Peru. Microbiol Resour Announc. 2020 May 7;9(19):e00303–20.
- Poterico JA, Mestanza O. Genetic variants and source of introduction of SARS-CoV-2 in South America. J Med Virol. 2020 May 13;92(10):2139–2145.
- Ramirez JD, Munoz M, Hernandez C, et al. Genetic diversity Among SARS-CoV2 strains in South America may impact Performance of molecular Detection. Pathogens. 2020 Jul 17;9(7):580.
- LaRed21. Primer caso autóctono de COVID-19 en Rivera: Hombre se habría contagiado en Brasil [First indigenous case of COVID-19 in Rivera: man would have been infected in Brazil]; 2020. Available from: https://www.lr21.com.uy/comunidad/1427746-primer-caso-autoctono-de-covid-19-en-rivera-hombre-se-habria-contagiado-en-brasil. Spanish.
- Subrayado. Metalworker from Rivera, who works in Livramento, first autochthonous case of Covid-19 2020. Available from: https://www.subrayado.com.uy/obrero-metalurgico-rivera-que-trabaja-livramento-primer-caso-autoctono-covid-19-n626618.
- Lemey P, Rambaut A, Welch JJ, et al. Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol. 2010 Aug;27(8):1877–1885.
- Asadu C. SOCIALDISTANCING: How one wedding guest infected 44 Uruguayans. The Cable. 2020. Available from: https://www.thecable.ng/s-o-c-i-a-l-d-i-s-t-a-n-c-i-n-g-how-one-wedding-guest-infected-44-uruguayans.
- El Observador. “Me decían que no era un caso grave”, dijo una de las uruguayas con coronavirus. [They told me it was not a serious case,” said one of the Uruguayans with coronavirus]. El Observador. 2020. Available from: https://www.elobservador.com.uy/nota/-me-decian-que-no-era-un-caso-grave-dijo-una-de-las-uruguayas-con-coronavirus-2020313194329. Spanish.
- Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020 Jul;583(7816):437–440.
- Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020 May 6;74(8):e13525.
- Toyoshima Y, Nemoto K, Matsumoto S, et al. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020 Jul 22;65(12):1075–1082.
- Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. Br Med J. 2020 May 22;369:m1966.
- Perez-Guzman PN, Daunt A, Mukherjee S, et al. Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study. Clin Infect Dis. 2020 Aug 7;ciaa1091.